Ofatumumab (Kesimpta) approved for relapsing MS in England and Wales
20 April 2021
The MS Trust is delighted that ofatumumab (Kesimpta) has been approved by NICE for people with active relapsing remitting multiple sclerosis.
Phoebe talks to us about being diagnosed with MS during lockdown.
19 April 2021
When the neurologist said the words ‘multiple sclerosis’, my immediate three questions were ‘Am I going to die?’, ‘Am I going to be disabled?’, ‘Can I have children?’
Under-the-skin injection of Tysabri gets licence in UK and Ireland
16 April 2021
Under-the-skin (subcutaneous) injection of Tysabri (natalizumab) has been approved for UK and Ireland.
Martin Baum on MS awareness week 2021
15 April 2021
As we approach another MS awareness week after what has been a very different last 12 months, Martin Baum reflects on the impact the coronavirus lockdown has had on him.
Covid-19 vaccines and people with MS: side effects and the second dose
15 April 2021
We've had a number of questions regarding possible side effects and also how to prepare for the second dose. To get some answers to these questions, we have once again spoken to neurologist Alasdair Coles from Addenbroke’s hospital in Cambridge.
Ofatumumab (Kesimpta) gets UK licence for relapsing remitting MS
14 April 2021
The MHRA has granted marketing authorisation for ofatumumab (Kesimpta) for active relapsing remitting MS.
Could you be an MSTV reporter?
1 April 2021
We are looking for young people with a connection to MS to join our team of MSTV reporters.
How long does it take for an MS drug to be fully effective?
31 March 2021
Researchers have investigated how long it takes for disease modifying drugs to be fully effective at reducing relapses and slowing progression.
Streaming for the win
12 March 2021
Anthony Chapman is a musician who was diagnosed with MS a few years ago. In this article we find out how he started streaming his beat making on Twitch and why he is helping the MS Trust make a theme tune for our new podcast series.
Al and Bee's Mission:100
10 March 2021
Siblings Al and Bee (9 and 8 years old) have been inspired to help those affected by multiple sclerosis by taking part in Mission:100 this year.
Through adversity comes strength
9 March 2021
"To forget the life where I once chose exclusion instead of inclusion would mean that I had learned nothing from a time when I chose to live MS and not life." Martin Baum looks at how MS prepared him for lockdown.
Do medicines reduce fatigue in MS?
8 March 2021
This study compared the effectiveness of amantadine, modafinil and methylphenidate with placebo in people with MS-related fatigue.
Sign up for updates from us
Keep up-to-date with the latest MS news, explore new research, read the stories of people living with MS, find out practical tips from MS experts, and discover exciting fundraising opportunities.